Protein Sciences Corporation - Product Pipeline Review – 2015 Is Released Protein Sciences Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct s, Protein Sciences Corporation - Product Pipeline Review - 2015, provides an overview of the Protein Sciences Corporation s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Protein Sciences Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-inclass products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Protein Sciences Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Protein Sciences Corporations human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement Latest news and deals relating to the Protein Sciences Corporations pipeline products Reasons to buy Evaluate Protein Sciences Corporations strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Protein Sciences Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Protein Sciences Corporation s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Protein Sciences Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Protein Sciences Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and 1
discontinued projects of Protein Sciences Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Browse Complete Report with TOC http://www.idatainsights.com/reports-landingpage.php?id=179147/protein-sciences-corporation-product-pipeline-review-2015 To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landingpage.php?id=179147/protein-sciences-corporation-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Protein Sciences Corporation Snapshot 5 Protein Sciences Corporation Overview 5 Key Information 5 Key Facts 5 Protein Sciences Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 Protein Sciences Corporation - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Protein Sciences Corporation - Pipeline Products Glance 11 Protein Sciences Corporation - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Phase III Products/Combination Treatment Modalities 12 Protein Sciences Corporation - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 2
Protein Sciences Corporation - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Protein Sciences Corporation - Drug Profiles 15 influenza [strains A/H1N1 + A/H3N2 + B] vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RIV-4 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 FluNhance 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 PanBlok 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 D-3252 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 3
Protein Sciences Corporation - Pipeline Analysis 22 Protein Sciences Corporation - Pipeline Products by Target 22 Protein Sciences Corporation - Pipeline Products by Route of Administration 23 Protein Sciences Corporation - Pipeline Products by Molecule Type 24 Protein Sciences Corporation - Recent Pipeline Updates 25 Protein Sciences Corporation - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 29 Disclaimer 30" width="80" height="40" />Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Protein Sciences Corporation Snapshot 5 Protein Sciences Corporation Overview 5 Key Information 5 Key Facts 5 Protein Sciences Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 4
Protein Sciences Corporation - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Protein Sciences Corporation - Pipeline Products Glance 11 Protein Sciences Corporation - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Phase III Products/Combination Treatment Modalities 12 Protein Sciences Corporation - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Protein Sciences Corporation - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Protein Sciences Corporation - Drug Profiles 15 influenza [strains A/H1N1 + A/H3N2 + B] vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 RIV-4 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 FluNhance 18 Product Description 18 5
Mechanism of Action 18 R&D Progress 18 PanBlok 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 D-3252 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Protein Sciences Corporation - Pipeline Analysis 22 Protein Sciences Corporation - Pipeline Products by Target 22 Protein Sciences Corporation - Pipeline Products by Route of Administration 23 Protein Sciences Corporation - Pipeline Products by Molecule Type 24 Protein Sciences Corporation - Recent Pipeline Updates 25 Protein Sciences Corporation - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 29 6
Disclaimer 30 Read More http://www.idatainsights.com/reports-landing-page.php?id=179147/protein-sciencescorporation-product-pipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.
7